Inventor · disambiguated record

Padmanabh Chivukula

Also filed as: CHIVUKULA PADMANABH

52 granted patents·27 pending applications·464 citations·filing 2011–2025

98Inventor score

Technology areasC12N A61K A61P C07C C07K

Files withARCTURUS THERAPEUTICS INC73 CHIVUKULA PADMANABH2 ULTRAGENYX PHARMACEUTICAL INC2 C/O ARCTURUS THERAPEUTICS INC1 US GOV SEC ARMY1

Top patents by PatentIndex Score

79 records

0198US10526284B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2017·Granted Jan 7, 2020·16 cites·17 claims
0298US9670152B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2016·Granted Jun 6, 2017·52 cites·19 claims
0398US9593077B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2014·Granted Mar 14, 2017·88 cites·23 claims
0498US9580711B2Lipid particles with asymmetric cationic lipids for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2016·Granted Feb 28, 2017·20 cites·20 claims
0598US9567296B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2015·Granted Feb 14, 2017·77 cites·6 claims
0698US9365610B2Asymmetric ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2015·Granted Jun 14, 2016·30 cites·17 claims
0797US10487105B2Trinucleotide MRNA cap analogsARCTURUS THERAPEUTICS INC·Filed 2017·Granted Nov 26, 2019·19 cites·12 claims
0897US9896413B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2017·Granted Feb 20, 2018·19 cites·20 claims
0996US10961188B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2019·Granted Mar 30, 2021·7 cites·20 claims
1096US10781169B2Method of synthesis of an ionizable cationic lipidARCTURUS THERAPEUTICS INC·Filed 2018·Granted Sep 22, 2020·6 cites·20 claims
1196US10227302B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2018·Granted Mar 12, 2019·12 cites·20 claims
1296US9850202B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2017·Granted Dec 26, 2017·15 cites·20 claims
1395US11744887B2Coronavirus vaccine compositions and methodsARCTURUS THERAPEUTICS INC·Filed 2021·Granted Sep 5, 2023·4 cites·28 claims
1495US10980895B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2019·Granted Apr 20, 2021·8 cites·20 claims
1595US10233148B2Aromatic ionizable cationic lipidARCTURUS THERAPEUTICS INC·Filed 2017·Granted Mar 19, 2019·6 cites·20 claims
1695US9951002B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2017·Granted Apr 24, 2018·12 cites·20 claims
1794US12220455B2Coronavirus vaccine compositions and methodsARCTURUS THERAPEUTICS INC·Filed 2023·Granted Feb 11, 2025·1 cites·33 claims
1894US10383952B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2016·Granted Aug 20, 2019·13 cites·16 claims
1993USRE49233EIonizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2019·Granted Oct 4, 2022·2 cites·25 claims
2093US10815463B2Messenger UNA molecules and uses thereofARCTURUS THERAPEUTICS INC·Filed 2017·Granted Oct 27, 2020·6 cites·19 claims
2193US9834510B2Aromatic ionizable cationic lipidARCTURUS THERAPEUTICS INC·Filed 2016·Granted Dec 5, 2017·4 cites·20 claims
2292US9856475B2Formulations for treating amyloidosisARCTURUS THERAPEUTICS INC·Filed 2015·Granted Jan 2, 2018·5 cites·18 claims
2390US11685906B2Compositions and methods for treating ornithine transcarbamylase deficiencyARCTURUS THERAPEUTICS INC·Filed 2019·Granted Jun 27, 2023·4 cites·25 claims
2489US11015204B2Synthesis and structure of high potency RNA therapeuticsARCTURUS THERAPEUTICS INC·Filed 2018·Granted May 25, 2021·6 cites·28 claims
2589US2025161434A1Coronavirus vaccine compositions and methodsARCTURUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
2688US12390524B2Compositions and methods for inducing immune responsesARCTURUS THERAPEUTICS INC·Filed 2023·Granted Aug 19, 2025·0 cites·22 claims
2788US11759515B2Compositions and methods for inducing immune responsesARCTURUS THERAPEUTICS INC·Filed 2021·Granted Sep 19, 2023·1 cites·27 claims
2888US10369232B2Allele selective gene editing and uses thereofARCTURUS THERAPEUTICS INC·Filed 2016·Granted Aug 6, 2019·14 cites·25 claims
2987USRE50681EIonizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2022·Granted Dec 2, 2025·0 cites·38 claims
3086US10421964B2UNA oligomers and compositions for treating amyloidosisARCTURUS THERAPEUTICS INC·Filed 2018·Granted Sep 24, 2019·2 cites·16 claims
3186US10399937B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2018·Granted Sep 3, 2019·2 cites·14 claims
3285US12070509B2Nucleic acids and methods of treatment for cystic fibrosisARCTURUS THERAPEUTICS INC·Filed 2021·Granted Aug 27, 2024·1 cites·34 claims
3385US9982259B2Transthyretin allele selective UNA oligomers for gene silencingARCTURUS THERAPEUTICS INC·Filed 2015·Granted May 29, 2018·5 cites·29 claims
3484US12398379B2Compositions and methods for treating ornithine transcarbamylase deficiencyARCTURUS THERAPEUTICS INC·Filed 2023·Granted Aug 26, 2025·0 cites·20 claims
3584US11737979B2Method of making lipid-encapsulated RNA nanoparticlesARCTURUS THERAPEUTICS INC·Filed 2020·Granted Aug 29, 2023·1 cites·19 claims
3684US2025304532A1Method of synthesis of an ionizable cationic lipidARCTURUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
3782US12290567B2Asialoglycoprotein Receptor mediated delivery of therapeutically active conjugatesARCTURUS THERAPEUTICS INC·Filed 2020·Granted May 6, 2025·1 cites·19 claims
3881US10968248B2Trinucleotide mRNA cap analogsC/O ARCTURUS THERAPEUTICS INC·Filed 2019·Granted Apr 6, 2021·2 cites·18 claims
3980US12220485B2Method of making lipid-encapsulated RNA nanoparticlesARCTURUS THERAPEUTICS INC·Filed 2023·Granted Feb 11, 2025·0 cites·20 claims
4080US10556861B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2017·Granted Feb 11, 2020·1 cites·15 claims
4179US11407800B2Translatable molecules and synthesis thereofARCTURUS THERAPEUTICS INC·Filed 2018·Granted Aug 9, 2022·1 cites·19 claims
4278US12286395B2Method of synthesis of an ionizable cationic lipidARCTURUS THERAPEUTICS INC·Filed 2020·Granted Apr 29, 2025·0 cites·18 claims
4378US11377643B2Therapeutics for glycogen storage disease type IIIULTRAGENYX PHARMACEUTICAL INC·Filed 2018·Granted Jul 5, 2022·1 cites·20 claims
4473US2021323914A1Ionizable cationic lipid for rna deliveryARCTURUS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
4573US2025136953A1Compositions and methods for the treatment of ornithine transcarbamylase deficiencyARCTURUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
4672US2025049950A1Nucleic acids and methods of treatment for cystic fibrosisARCTURUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
4771US11939363B2Translatable molecules and synthesis thereofARCTURUS THERAPEUTICS INC·Filed 2022·Granted Mar 26, 2024·0 cites·20 claims
4869US12509698B2Synthesis and structure of high potency RNA therapeuticsARCTURUS THERAPEUTICS INC·Filed 2021·Granted Dec 30, 2025·0 cites·18 claims
4968US2025177305A1Method of making lipid-encapsulated rna nanoparticlesARCTURUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
5066US2022340886A1Therapeutics for glycogen storage disease type iiiULTRAGENYX PHARMACEUTICAL INC·Filed 2022·Application pending·0 cites

Showing the top 50 of 79 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when Padmanabh Chivukula files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →